A carregar...
RPL19 Is a Prognostic Biomarker and Promotes Tumor Progression in Hepatocellular Carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most common malignancies, and the therapeutic outcome remains undesirable due to its recurrence and metastasis. Gene dysregulation plays a pivotal role in the occurrence and progression of cancer, and the molecular mechanisms are largely unkno...
Na minha lista:
| Publicado no: | Front Cell Dev Biol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8327752/ https://ncbi.nlm.nih.gov/pubmed/34350180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2021.686547 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|